ELLIPSES PHARMA LTD

09542015
Active London

Other professional, scientific and technical activities n.e.c.

32 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
E

ELLIPSES PHARMA LTD

09542015

Other professional, scientific and technical activities n.e.c.

Founded 14 Apr 2015 Active London, England 32 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
Accounts Submitted 3 Apr 2026 Next due 31 Mar 2026 4 months overdue
Confirmation Submitted 13 Mar 2026 Next due 21 Mar 2027 8 months remaining
Net assets £-7M £28M 2024 year on year
Total assets £29M £6M 2024 year on year
Total Liabilities £35M £23M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

10 Stratton Street London W1J 8LG England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for ELLIPSES PHARMA LTD (09542015), an active life sciences and medical technology company based in London, England. Incorporated 14 Apr 2015. Other professional, scientific and technical activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type group
Next accounts 31 Mar 2025
Due by 31 Mar 2026 4 months overdue

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£16.73M

Decreased by £9.19M (-35%)

Net Assets

-£6.66M

Decreased by £28.22M (-131%)

Total Liabilities

£35.22M

Increased by £22.68M (+181%)

Turnover

N/A

Employees

32

Increased by 3 (+10%)

Debt Ratio

123%

Increased by 86 (+232%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (3)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jul 2023Unknown/Other
Investor 2Jul 2023Unknown/Other
Investor 3Jul 2023Unknown/Other

Share Capital

Share Capital

Share allotments and capital structure

32 Allotments 84,861,066 Shares £159.32m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
19 Jun 2026850,000£3.83m£4.5
19 Jun 2026850,000£3.83m£4.5
23 Dec 20255,042,432£22.69m£4.5
23 Dec 2025500,000£2.25m£4.5
23 Dec 20252,246,500£2k£0.001

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (69)

Eaststart Capital Limited
46.4%
63,247,178
Ectoplasm Limited
13.0%
17,776,062

Persons with Significant Control

Persons with Significant Control (0)

0 Active 4 Ceased

Christopher Chipperton

Ceased 19 Dec 2018

Ceased

Mr Ali Ahmed Abd Al Mouhsen Alfrayhat

Ceased 12 Feb 2026

Ceased

Christopher Thomas Evans

Ceased 19 Dec 2018

Ceased

Ectoplasm Limited

Ceased 19 Dec 2018

Ceased

Group Structure

Group Structure

ELLIPSES PHARMA LTD Current Company
YETI THORN LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Fifth Floor, 10 Stratton Street, London (W1J 8LG) CITY OF WESTMINSTER
Leasehold-16 Jul 2019
Fifth Floor, 10 Stratton Street, London (W1J 8LG)
Leasehold
Added 16 Jul 2019
District CITY OF WESTMINSTER

Documents

Company Filings

DateCategoryDescriptionDocument
25 Jun 2026MiscellaneousReplacement filing of SH01 - 23/06/26 Statement of Capital gbp 137127.831
23 Jun 2026CapitalAllotment of shares (GBP 137,145.475) on 19 Jun 2026
23 Jun 2026CapitalAllotment of shares (GBP 137,145.475) on 19 Jun 2026
3 Apr 2026AccountsAnnual accounts made up to 31 Mar 2025
13 Mar 2026Confirmation StatementConfirmation statement made on 7 Mar 2026 with updates
25 Jun 2026 Miscellaneous

Replacement filing of SH01 - 23/06/26 Statement of Capital gbp 137127.831

23 Jun 2026 Capital

Allotment of shares (GBP 137,145.475) on 19 Jun 2026

23 Jun 2026 Capital

Allotment of shares (GBP 137,145.475) on 19 Jun 2026

3 Apr 2026 Accounts

Annual accounts made up to 31 Mar 2025

13 Mar 2026 Confirmation Statement

Confirmation statement made on 7 Mar 2026 with updates

Recent Activity

Latest Activity

Replacement filing of SH01 - 23/06/26 Statement of Capital gbp 137127.831

1 weeks ago on 25 Jun 2026

Allotment of shares (GBP 137,145.475) on 19 Jun 2026

1 weeks ago on 23 Jun 2026

Allotment of shares (GBP 137,145.475) on 19 Jun 2026

1 weeks ago on 23 Jun 2026

Annual accounts made up to 31 Mar 2025

3 months ago on 3 Apr 2026

Confirmation statement made on 7 Mar 2026 with updates

3 months ago on 13 Mar 2026